Development of the treatment adherence survey-patient version (TAS-P) for OCD
Development of the treatment adherence survey-patient version (TAS-P) for OCD
复制标题
DOI：
10.1016/j.janxdis.2007.01.009
复制
发表时间：
2008-01-01
影响因子：
10.3
通讯作者：
Eisen, Jane L.
中科院分区：
文献类型：
--
作者：
Mancebo, Maria C.;Pinto, Anthony;Eisen, Jane L.
本文报告了治疗依从性调查患者版本（TAS-P）的开发和初步心理测量评估，这是一种旨在评估患者对认知行为治疗（CBT）和药物治疗建议的依从性的简要工具。80名强迫症（OCD）患者接受了TAS-P，作为OCD过程前瞻性观察性研究的一部分。结果显示了良好的重测信度。对TAS-P的反应也与一般治疗依从性的自我报告测量评分以及从图表审查中收集的数据显著相关，证明了同时有效性。人口统计学变量不能解释治疗依从性。然而，报告不遵守CBT建议的参与者在摄入时比不支持CBT不遵守的参与者有更严重的强迫症症状（平均Y-BOCS = 23.27 +/- 7.5 vs 18.20 +/- 8.0，分别）。结果表明，TAS-P是一种很有前途的工具，用于评估不遵守CBT和药物治疗干预建议的原因。(C)2007爱思唯尔有限公司保留所有权利。
This paper reports on the development and initial psychometric evaluation of the Treatment Adherence Survey-patient version (TAS-P), a brief instrument designed to assess patient adherence to Cognitive-Behavioral Therapy (CBT) and pharmacotherapy recommendations for OCD. Eighty individuals with Obsessive Compulsive Disorder (OCD) were administered the TAS-P as part of the intake interview of a prospective, observational study of the course of OCD. Results demonstrated excellent test-retest reliability. Responses on the TAS-P were also significantly correlated with scores on a self-report measure of general treatment adherence and with data collected from a chart-review, demonstrating concurrent validity. Treatment adherence was not explained by demographic variables. However, participants who reported nonadherence to CBT recommendations had more severe OCD symptoms at the time of intake than those who did not endorse CBT nonadherence (mean Y-BOCS = 23.27 +/- 7.5 versus 18.20 +/- 8.0, respectively). Results suggest that the TAS-P is a promising instrument for assessing reasons for nonadherence to recommendations for CBT and pharmacotherapy interventions. (C) 2007 Elsevier Ltd. All rights reserved.